Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC

<< Previous

Bullboard Posts

Next >>

Comment by Conquistador1on May 20, 2022 10:26am

217 Views

Post# 34698136

RE:RE:RE:RE:ONC

Kswdelux,
ONC announced that the warrants will expire on June 1st. They could have repriced them for you, to give you a chance to exercise them, but I guess they didn't need the cash.
I just bought a 1000 shares (This represents my low confidence index.). I will be selling these if the stock gets close to $2. Some years ago, I had bought a 100000 shares. I experienced too much angst with this position, even though it was profitable for me.

<< Previous

Bullboard Posts

Next >>

Viva Gold brings new drill program and updated PEA to Nevada project